Theralase Technologies Inc. (TLTFF)
USD 0.14
(-2.28%)
USD 0.14
(-2.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 562.13 Thousand CAD | -16.39% |
| 2022 | 5.85 Million CAD | 20.78% |
| 2021 | 4.85 Million CAD | -18.69% |
| 2020 | 5.96 Million CAD | -20.24% |
| 2019 | 7.48 Million CAD | 73.37% |
| 2018 | 4.31 Million CAD | -42.33% |
| 2017 | 7.48 Million CAD | 24.1% |
| 2016 | 6.02 Million CAD | -8.21% |
| 2015 | 6.56 Million CAD | 87.54% |
| 2014 | 3.5 Million CAD | 84.05% |
| 2013 | 1.9 Million CAD | -30.52% |
| 2012 | 2.73 Million CAD | -3.84% |
| 2011 | 2.84 Million CAD | 10.58% |
| 2010 | 2.57 Million CAD | 42.94% |
| 2009 | 1.8 Million CAD | -24.66% |
| 2008 | 2.39 Million CAD | 5.94% |
| 2007 | 2.25 Million CAD | 66.43% |
| 2006 | 1.35 Million CAD | 51.12% |
| 2005 | 897.63 Thousand CAD | 115.22% |
| 2004 | 417.08 Thousand CAD | 548.71% |
| 2003 | 64.29 Thousand CAD | 26.73% |
| 2002 | 50.73 Thousand CAD | -0.66% |
| 2001 | 51.07 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.46 Million CAD | 26.5% |
| 2024 Q2 | 1.1 Million CAD | -98.09% |
| 2023 Q4 | 1.15 Million CAD | -0.28% |
| 2023 Q1 | 1.5 Million CAD | 38.68% |
| 2023 FY | 4.89 Million CAD | -16.39% |
| 2023 Q2 | 1.2 Million CAD | -20.05% |
| 2023 Q3 | 1.15 Million CAD | -3.85% |
| 2022 Q4 | 1.08 Million CAD | -29.06% |
| 2022 Q2 | 1.43 Million CAD | -20.37% |
| 2022 Q3 | 1.53 Million CAD | 6.69% |
| 2022 Q1 | 1.8 Million CAD | 35.47% |
| 2022 FY | 5.85 Million CAD | 20.78% |
| 2021 Q2 | 1.28 Million CAD | 16.82% |
| 2021 FY | 4.85 Million CAD | -18.69% |
| 2021 Q4 | 1.33 Million CAD | 18.18% |
| 2021 Q3 | 1.12 Million CAD | -12.62% |
| 2021 Q1 | 1.1 Million CAD | 8.17% |
| 2020 FY | 5.96 Million CAD | -20.24% |
| 2020 Q3 | 1.53 Million CAD | -9.8% |
| 2020 Q2 | 1.69 Million CAD | -1.17% |
| 2020 Q1 | 1.71 Million CAD | -41.69% |
| 2020 Q4 | 1.02 Million CAD | -33.35% |
| 2019 Q1 | 1.16 Million CAD | 19.12% |
| 2019 Q2 | 1.55 Million CAD | 33.75% |
| 2019 Q3 | 1.82 Million CAD | 17.65% |
| 2019 Q4 | 2.94 Million CAD | 61.32% |
| 2019 FY | 7.48 Million CAD | 73.37% |
| 2018 Q2 | 1.17 Million CAD | -2.44% |
| 2018 FY | 4.31 Million CAD | -42.33% |
| 2018 Q4 | 974.01 Thousand CAD | 0.58% |
| 2018 Q1 | 1.2 Million CAD | -33.55% |
| 2018 Q3 | 968.36 Thousand CAD | -17.35% |
| 2017 Q4 | 1.8 Million CAD | -0.68% |
| 2017 Q3 | 1.81 Million CAD | -12.28% |
| 2017 FY | 7.48 Million CAD | 24.1% |
| 2017 Q1 | 1.78 Million CAD | 34.61% |
| 2017 Q2 | 2.07 Million CAD | 16.5% |
| 2016 Q2 | 1.58 Million CAD | 11.64% |
| 2016 Q4 | 1.32 Million CAD | -20.43% |
| 2016 Q3 | 1.66 Million CAD | 5.07% |
| 2016 FY | 6.02 Million CAD | -8.21% |
| 2016 Q1 | 1.41 Million CAD | -9.71% |
| 2015 Q2 | 1.55 Million CAD | 31.16% |
| 2015 FY | 6.56 Million CAD | 87.54% |
| 2015 Q1 | 1.18 Million CAD | 9.58% |
| 2015 Q4 | 1.56 Million CAD | -30.44% |
| 2015 Q3 | 2.25 Million CAD | 45.03% |
| 2014 Q3 | 1.12 Million CAD | 53.34% |
| 2014 Q2 | 733.9 Thousand CAD | 30.95% |
| 2014 Q1 | 560.44 Thousand CAD | 18.71% |
| 2014 FY | 3.5 Million CAD | 84.05% |
| 2014 Q4 | 1.08 Million CAD | -3.8% |
| 2013 FY | 1.9 Million CAD | -30.52% |
| 2013 Q4 | 472.11 Thousand CAD | 14.97% |
| 2013 Q3 | 410.63 Thousand CAD | -11.01% |
| 2013 Q2 | 461.42 Thousand CAD | -17.42% |
| 2013 Q1 | 558.75 Thousand CAD | -16.82% |
| 2012 Q4 | 671.74 Thousand CAD | 7.52% |
| 2012 Q1 | 750.52 Thousand CAD | 30.25% |
| 2012 Q2 | 695.32 Thousand CAD | -7.35% |
| 2012 FY | 2.73 Million CAD | -3.84% |
| 2012 Q3 | 624.78 Thousand CAD | -10.15% |
| 2011 Q4 | 576.22 Thousand CAD | -20.64% |
| 2011 Q1 | 721.85 Thousand CAD | 6.58% |
| 2011 Q2 | 823.91 Thousand CAD | 14.14% |
| 2011 Q3 | 726.08 Thousand CAD | -11.87% |
| 2011 FY | 2.84 Million CAD | 10.58% |
| 2010 Q2 | 632.75 Thousand CAD | 11.54% |
| 2010 Q4 | 677.3 Thousand CAD | -3.0% |
| 2010 FY | 2.57 Million CAD | 42.94% |
| 2010 Q1 | 567.31 Thousand CAD | 31.8% |
| 2010 Q3 | 698.25 Thousand CAD | 10.35% |
| 2009 Q4 | 430.44 Thousand CAD | 5.26% |
| 2009 Q1 | 506.28 Thousand CAD | -22.33% |
| 2009 Q2 | 456.28 Thousand CAD | -9.88% |
| 2009 Q3 | 408.93 Thousand CAD | -10.38% |
| 2009 FY | 1.8 Million CAD | -24.66% |
| 2008 Q4 | 651.88 Thousand CAD | 15.2% |
| 2008 Q1 | 566.06 Thousand CAD | -42.83% |
| 2008 Q2 | 608.01 Thousand CAD | 7.41% |
| 2008 Q3 | 565.89 Thousand CAD | -6.93% |
| 2008 FY | 2.39 Million CAD | 5.94% |
| 2007 Q2 | 418.81 Thousand CAD | 6.61% |
| 2007 FY | 2.25 Million CAD | 66.43% |
| 2007 Q3 | 455.94 Thousand CAD | 8.86% |
| 2007 Q4 | 990.12 Thousand CAD | 117.16% |
| 2007 Q1 | 392.86 Thousand CAD | -37.64% |
| 2006 Q2 | 269.91 Thousand CAD | 40.99% |
| 2006 FY | 1.35 Million CAD | 51.12% |
| 2006 Q3 | 265.21 Thousand CAD | -1.74% |
| 2006 Q4 | 629.95 Thousand CAD | 137.53% |
| 2006 Q1 | 191.43 Thousand CAD | -42.42% |
| 2005 Q2 | 186.44 Thousand CAD | 23.85% |
| 2005 FY | 897.63 Thousand CAD | 115.22% |
| 2005 Q4 | 332.48 Thousand CAD | 45.72% |
| 2005 Q1 | 150.53 Thousand CAD | -4.02% |
| 2005 Q3 | 228.16 Thousand CAD | 22.38% |
| 2004 FY | 417.08 Thousand CAD | 548.71% |
| 2004 Q3 | 99.24 Thousand CAD | 10.38% |
| 2004 Q4 | 156.83 Thousand CAD | 58.02% |
| 2004 Q2 | 89.91 Thousand CAD | 27.95% |
| 2004 Q1 | 70.27 Thousand CAD | 203.8% |
| 2003 Q2 | 11.61 Thousand CAD | -10.52% |
| 2003 Q1 | 12.97 Thousand CAD | 19.58% |
| 2003 Q3 | 16.57 Thousand CAD | 42.71% |
| 2003 FY | 64.29 Thousand CAD | 26.73% |
| 2003 Q4 | 23.13 Thousand CAD | 39.59% |
| 2002 Q2 | 11.44 Thousand CAD | -2.98% |
| 2002 Q4 | 10.85 Thousand CAD | -34.83% |
| 2002 Q3 | 16.65 Thousand CAD | 45.47% |
| 2002 FY | 50.73 Thousand CAD | -0.66% |
| 2002 Q1 | 11.79 Thousand CAD | 0.0% |
| 2001 FY | 51.07 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 66.847% |
| ALR Technologies Inc. | 6.33 Million USD | 91.128% |
| Aurora Spine Corporation | 8.65 Million USD | 93.507% |
| AVITA Medical, Inc. | 80.77 Million USD | 99.304% |
| Avitar, Inc. | 3.56 Million USD | 84.252% |
| BioElectronics Corporation | 740.67 Thousand USD | 24.105% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Broncus Holding Corporation | 38.15 Million USD | 98.527% |
| Brain Scientific Inc. | 9.66 Million USD | 94.182% |
| BrainsWay Ltd. | 28.01 Million USD | 97.994% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 11.431% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -826.116% |
| CVR Medical Corp. | - USD | -Infinity% |
| NIOX Group Plc | 22.27 Million USD | 97.477% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -29.078% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -37.952% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 97.419% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 81.928% |
| Escalon Medical Corp. | 5.25 Million USD | 89.294% |
| Lombard Medical, Inc. | 30.29 Million USD | 98.144% |
| Fuse Medical, Inc. | 10.35 Million USD | 94.569% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 83.907% |
| Heart Tronics, Inc. | 14.46 Million USD | 96.113% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 98.326% |
| Ingen Technologies, Inc. | 1.88 Million USD | 70.135% |
| IR-Med Inc. | 4.89 Million USD | 88.514% |
| Kelyniam Global, Inc. | 2.27 Million USD | 75.293% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.946% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | 20.038% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 57.43% |
| Nanomix Corporation | 8.36 Million USD | 93.282% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -366.401% |
| NewCardio, Inc. | 9.56 Million USD | 94.123% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 90.55% |
| Odyssey Group International, Inc. | -14.26 Million USD | 103.942% |
| Össur hf. | 396.18 Million USD | 99.858% |
| Össur hf. | 396.18 Million USD | 99.858% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 94.544% |
| Polarean Imaging plc | 12.24 Million USD | 95.408% |
| Positron Corporation | 1 Million USD | 44.193% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -172.327% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -144.15% |
| Vivos Inc. | 2.78 Million USD | 79.831% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 44.612% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 55.504% |
| Smith & Nephew plc | 3.46 Billion USD | 99.984% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 96.028% |
| SS Innovations International, Inc. | 21.38 Million USD | 97.371% |
| Stratec SE | 46.32 Million USD | 98.786% |
| Theraclion SA | 7.43 Million USD | 92.444% |
| United American Healthcare Corporation | 59 Thousand USD | -852.769% |
| Urologix, Inc. | 10.09 Million USD | 94.43% |
| QHSLab, Inc. | 961.65 Thousand USD | 41.545% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| VMS Rehab Systems, Inc. | 63.63 USD | -883341.773% |
| Vycor Medical, Inc. | 1.27 Million USD | 55.927% |
| Wellness Center USA, Inc. | 1.29 Million USD | 56.578% |
| Wellstar International, Inc. | 1.79 Million USD | 68.678% |
| Zecotek Photonics Inc. | 3.46 Million USD | 83.76% |